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Abstract

Perinatal genetic counseling is a health service provided to patients
who carry risk factors for genetic abnormalities for their offspring. There are
several non-invasive and invasive tests offered to patients in order to provide
genetic information about possible disorders. The non-invasive screens
calculate a percentage of risk relative to average population risk. If the noninvasive screens predict an elevated risk, a more invasive test can be offered
to obtain definitive results about possible disorders in the pregnancy. The
most commonly used invasive test is called amniocentesis and it carries a risk
for pregnancy complications. After receiving abnormal results on the noninvasive screens, patients have the option to continue with invasive testing to
obtain definitive results.
This project sought to discern factors predictive of testing choice after
abnormal screen results. From 134 patient charts that fit certain criteria,
several factors such as screen-calculated risk were analyzed and evaluated
using a statistical analysis program.
Of the factors analyzed, a trend in the data can be seen. The higher a
woman’s calculated risk of genetic abnormality in the fetus, the more likely
she was to continue onto invasive testing.
This research has future implications for the field of genetic
counseling. The more information there is concerning testing implications and
testing choice, the better the care that health professionals will be able to
provide.

Table of Contents

Acknowledgements……………………………………….i
Introduction……………………………………………….1
Methods and Materials……………………………………8
Results…………………………………………………...10
Discussion……………………………………………….17
Works Cited……………………………………………..22
Capstone Summary……………………………………...23

i

Acknowledgements

I would like to thank Dr. Robert Roger Lebel for his mentoring and
advising throughout this entire project. I would like to thank him for providing
me with files, guiding me through data collection, and with his assistance in
the analysis of my research.
I would also like to thank Karen Fay, M.S. for allowing me to sit in on
many genetic counseling sessions and for explaining many facets of the
genetic counseling profession to me.
Last but not least, I would like to thank Dr. Kari Segraves. Her passion
for research inspired me to aspire to more than I had originally thought.
Without her guidance and encouragement, I would not have been able to write
this Capstone. She is integral to my personal growth as a biologist and
researcher and to her I am extremely grateful.

The Basis and Implications of Genetic Counseling in Patient Testing Choice

Introduction
Genetic counseling can be defined as a “process in which a genetic
counselor educates families or individuals about their risk of passing on a
genetic predisposition for certain disorders to future generations” (National
Society of Genetic Counselors 2011). To achieve this goal, a genetic
counselor will explain and discuss the patient’s current medical situation with
the patient in order to inform and educate. During this counseling, the patients
will be presented with the medical facts as well as a possible diagnosis. They
will be taken through the likely progression of the disorder as well as possible
treatments or cures. Another goal of the genetic counseling session is for the
patient to understand the inheritance of their possible affliction and how their
medical history has contributed to the possible occurrence. With clear
explanation of this information, the genetic counselor will also provide future
options, such as testing and screens or support and referrals to other
specialists. Overall, the goal of the genetic counselor is to inform the patients
of how genetic history can affect medical future.
Although genetic counseling can be provided to any patient for any
medical situation, genetic counseling is especially commonly offered to
pregnant women. There are many medical factors that might cause a woman
to have a “high-risk pregnancy,” and if she does, she will likely be referred to
a genetic counselor. The possible factors that can denote a possible high-risk

pregnancy are many, each with a medical basis that might affect the
pregnancy adversely. The first is “advanced maternal age”, where the mother
will be 35 years or more at the age of delivery. This is a contributor to a highrisk pregnancy, as many studies have shown that women over 35 have “an
increase in intercurrent illness and pregnancy complications” (Jacobsson,
Ladfors, and Milsom 2004).
Women over the age of 35 also have “an increased risk for miscarriage
and for chromosomal abnormalities…and fetal/neonatal congenital
anomalies” (Cleary-Goldman et al. 2005). As the mother ages, so do the
viable cells that might be fertilized to produce a pregnancy. This aging in cells
is related to cellular division, and cells that do not divide properly may result
in chromosomal nondisjunction (Dailey et al. 1996). The normal number of
chromosomes in a human is 46: 23 from the mother and 23 from the father.
During meiosis, germ cells divide from these 46 chromosomes to haploid cells
containing 23 chromosomes, and at fertilization, return to the diploid state of
46 chromosomes. If one chromosome pair does not divide properly, this
results in nondisjunction, and the fetus resulting from fertilization will have an
abnormal number of chromosomes. This abnormal number typically means
that the fetus will have three or only one of a certain chromosome instead of
two, and this results in fetal disorders, which denote a high-risk pregnancy.
Another factor indicative of a high-risk pregnancy is fetal
abnormalities that might be observed on an ultrasound. “Routine ultrasound
screening…has the potential advantage of detecting most major fetal

malformations” (Milunsky 2004). If such an anomaly is noted, a woman will
be referred to a genetic counselor because of the high congruency of fetal
abnormalities and genetic disease.
Previous pregnancy complications of the patient or the patient’s family
can be indicative of a future high-risk pregnancy. If a woman has had one or
more miscarriages or stillbirth or neonatal death in a previous pregnancy, this
will be a cause for concern, and lead to a referral to a genetic counselor. Also,
if there is a clear indication in the patient’s family medical history of a
heritable genetic disorder, this will raise alarm in the possibility of a high-risk
pregnancy with this same genetic disorder. Similarly, if there is a family
history of structural anomalies, again there may be potential for a high-risk
pregnancy. If the family medical history contains individuals that have
presented with neural tube defects, congenital heart defects, or cleft lip and
palate, there is potential for recurrence in a future pregnancy, indicating the
need for discussion of risk with a genetic counselor.
Consultation is also recommended to the patient if the patient has an
ethnic background with a disorder that occurs more commonly than in the
general population. Examples of this include cystic fibrosis in Europeans,
Tay-Sachs disease in Orthodox Jews and Eastern Europeans, and sickle-cell
anemia in African Americans. If the patient is a member of such an ethnic
group, a referral to a genetic counselor is recommended in that there can be
prenatal diagnosis of a disorder or carrier testing for early detection of the
disorder. A less likely family-related risk factor is consanguinity, where the

parents are related, for example if the parents are first cousins. Consanguinity
produces an increased risk of fetal disorders, because the parents may both
carry the same defective gene and can pass it on to the fetus. If the pregnancy
is the result of a consanguineous union, then genetic counseling is
recommended. Moreover, there are many other less common factors that
might indicate high-risk pregnancies such as history of or suspected
metabolism abnormality, history of or suspected chromosomal rearrangement,
or a family history of mental retardation or developmental disabilities.
Currently it is routine to offer pregnant women serum screens that can
test the mother’s blood for indicators of abnormalities in the pregnancy.
Abnormal maternal serum marker screening results will cause a woman to be
referred to a genetic counselor for discussion of risk in the pregnancy. After
an abnormal result and consultation with the genetic counselor, the patient has
the option to continue on to more invasive testing. Although there are many
maternal serum marker screens, two of the most common are the Maternal
Serum Alpha-Fetoprotein (MSAFP) and the Triple Screen.
The MSAFP test is a blood test that evaluates the levels of alphaprotein in the mother’s serum. This test is usually given between the 14th and
22nd weeks of pregnancy. The test recognizes abnormal levels of alphafetoprotein relative to a normal range and out-of-range values can predict the
risk of a disorder in the fetus. This test has utility as a single analyte screen
because if the alpha-fetoprotein level is high relative to the normal, this can

indicate the possible presence of a neural tube defect. Conversely, low levels
of alpha-fetoprotein can indicate Down Syndrome.
The Triple Screen expands analysis from the MSAFP and measures
two other analytes. This screen is primarily given to women who are between
their 15th and 21st week of pregnancy, where it evaluates the levels of three
analytes from the placenta and the fetus in order to predict elevated risk for
the following fetal abnormalities; Down Syndrome (Trisomy 21), Edwards
Syndrome (Trisomy 18), and Neural Tube Defects (NTD). Alpha-fetoprotein
(AFP) is found in amniotic fluid and abnormal levels of this may indicate the
presence of a fetal disorder. Human chorionic gonadotopin (hCG) is a protein
produced by the placenta. Unconjugated estriol (uE3) is made in the fetus and
placenta. Based on extensive studies of levels of these hormones, a prediction
can be made as to the possible abnormality in a fetus. The screen can detect
“Down Syndrome in 69% of cases and…neural tube defects in 80% of the
cases” (American College of Obstetrics and Gynecology 2007). If the levels
of all three analytes are low, this is an indication for Trisomy 18. Also, the test
is dependant on the predicted age of the fetus, so an incorrectly assessed age
could result in perceived abnormal protein levels.
It is a common misconception that, since these screens do not detect
all cases of fetal abnormalities, these screens are not accurate. The screens
accurately test analyte levels and return a calculated risk. Also, an elevated
calculated risk does not absolutely mean that there is an abnormality in the
fetus. The elevated calculated risk is the analyte level relative to baseline

population risk. Although they do not detect all cases of fetal abnormalities,
their ability to detect possible fetal disorders makes them very useful to
prenatal genetic screening.
Once either of these screens has established an abnormal level of
analytes, possibly indicating a disorder in the fetus, the patient has the option
to continue on to an ultrasound or a more invasive form of testing. Ultrasound
uses sound waves to visualize the fetus and its body structures. Ultrasound is
non-invasive and commonly used to detect abnormalities that have physical
manifestations. Also, ultrasound allows for “the detection of not only major
malformations but also subtle markers of chromosomal abnormalities and
genetic syndromes” (Milunsky 2004). For example, fetuses with Down
Syndrome often have thick skin at the posterior section of the neck (nuchal
fold) and the size of this can be measured on an ultrasound. This procedure
assists in diagnosis of possible genetic disorders in the fetus.
The most common invasive test performed in this situation is
amniocentesis. Amniocentesis is considered invasive because the test entails
the use of a needle to enter the amniotic sac and withdraw approximately 15 –
30 mL of amniotic fluid for testing. Under ultrasound guidance, the physician
will find the precise location of the fetus, and point the needle towards an area
of the amniotic sac that only contains fluid. Then the fluid is extracted and the
needle is removed. The entire procedure takes about two minutes. The
amniotic fluid that is withdrawn carries valuable information about the fetus,
including the possible occurrence of Down Syndrome. Also, the test provides

a full karyotype of the chromosomes of the fetus, enabling chromosomal
studies and prediction of possible genetic disorders. Although this test
provides extremely useful diagnostic information, it carries risk factors for the
pregnancy because of its invasive nature. These risk factors “can include
rupture of the membranes and subsequent miscarriage” (Sloane 144). The
estimated increase risk of miscarriage as a result of amniocentesis is
approximately 0.2% (R. Lebel, personal communication). As amniocentesis
carries the risk of pregnancy complications, the decision to continue from
non-invasive to invasive testing is one that often takes much consideration on
the part of the patient.
This decision to move from non-invasive testing to more definitive
invasive testing in the case of a pregnancy with genetic disorder risk is one
that entails many different factors. The various factors that might affect this
decision are of particular interest to me, in that they may be predictive of
testing choice and they can show the effect of testing on patient choice. While
the actual factors that can affect this decision are numerous, the ones that are
readily evaluated are age of the patient, the patient’s population risk for a
disorder of the fetus, the MSAFP or Triple Screen screen-calculated risk, and
whether previous children of the patient have genetic disorders. Another
factor that might affect the decision to continue onto invasive testing is the
income of the patient. There is a high correlation between income and
education level (Day & Newburger 2002). Income is often an indicator of
education level, and education level is often an indicator of the patient’s

ability to perceive statistics and calculated risk. As each of these affects
patient outlook, they may influence a patient’s choice to continue with
invasive testing after a non-invasive screen produces abnormal results.

Methods and Materials
In order to conduct a study that evaluates the possible factors that
might affect patient testing decisions, subjects that fit certain criteria were
obtained. Dr. Robert Roger Lebel provided his patient files that ranged from
1997 to 2003. Because they had reached the statutory limit for medical
records after closing of a physician’s practice, these charts were all in the
process of being destroyed. This rendered them beyond any possible contact
to the patients, and thus satisfied the criteria of the Institutional Review Board
of the SUNY Upstate Medical University, to allow use of identifying
information. The protocol was approved.
These patients were seen in Dr. Lebel’s practice in Glen Ellyn, Illinois.
From these patients, I selected those that fit specific criteria. Patients had
elected to have either the Triple Screen or MSAFP test performed by their
obstetricians. After having the test performed, they received an abnormal
result and were referred to Dr. Lebel to discuss their result. After they had the
consultation, they made the decision whether to have no more procedures at
all, an ultrasound only, or ultrasound with amniocentesis. From the patient
charts that fit these criteria, I recorded additional information on a sheet
specific to each chart. I recorded the patient’s age at delivery and the

population risk that was told to the patient. Dr. Lebel told the population risk
to the patient as based on Hook 1981. This value was given as a number
denoting the possible occurrence of a genetic disorder at that age out of 1000
women of that age. I also recorded the patient’s decision after the discussion
of their screen result. I recorded the result of the ultrasound if the patient
chose to have one as well as the result of the amniocentesis if the patient
chose to have one. Also I recorded the screen-calculated risk, given as 1 out of
denominator, denoting the chance of a genetic disorder occurring in the fetus
relative to baseline population risks for pregnant women of that age. I
recorded whether the women had children previous to the pregnancy in
question, and whether those children were healthy or not. Also recorded were
the patient’s marital status, previous miscarriages, a family history of genetic
disorders, a family history of miscarriage or stillbirth, and the patient’s
ethnicity but preliminary analysis did not yield any results with statistical
significance.
In total, 134 charts fit the selection criteria. Data were entered into a
Microsoft Excel spreadsheet for the purpose of organization. Zip codes were
used to estimate the median income of the patient’s neighborhood based on
the 2000 Census data of average income (US Census Bureau 2000). The
calculated risk and population risks were converted into percentages. For
statistical analysis, IBM® SPSS® Statistics V. 18 was used. A one-way
analysis of variance (ANOVA), was used to determine whether decision was
affected by calculated risk or income. A chi-square analysis was done to

determine whether decision to choose an invasive test was dependent on the
presence of previous unhealthy children. A regression analysis was done to
examine the relationship between the age of patient and their screencalculated risk.

Results
Figure 1 is a graph of the population risk depending on the age of the
patient at delivery. The data are based on Hook’s values as told to the patients.
Hook’s data shows that women over the age of 35 are at higher risk of a
chromosomal abnormality occurring in their pregnancy. Before the age of 35,
the risk of a disorder in pregnancy is relatively low and has a very gradual
slope of increase until the age of 35. However, after the age of 35, the slope
and risk of disorder in pregnancy increased exponentially. This explains the
concern for pregnancies in women who are older and supports genetic
counseling as an option for women who have pregnancies later in life. The
population risk is calculated as a percentage, such as 0.1% chance of
chromosome abnormality in the fetus, which corresponds to a graph value of
0.001.

Figure 1. Population risk of chromosomal abnormalities in the
fetus by age of the mother at delivery. These values are based on
Hook’s data (Hook 1981). Population risk is given as a
percentage, where .001 means 0.1% chance of an abnormality
Figure 2 depicts the distribution of patients making each possible
decision. Out of 134 patients, 12 patients made the decision to not continue to
any procedure at all and this is denoted by decision = 0. Twenty-nine patients
made the decision to have ultrasound only and this is denoted by decision = 1.
Ninety-three patents made the decision to have both an amniocentesis and an
ultrasound and this is denoted by decision = 2. This shows that 9% of the
patients surveyed chose no procedure, 22% chose to have ultrasound only, and
69% chose to have ultrasound and amniocentesis. Overall, 91% of the patients

chose to have some procedure, whether it was ultrasound only or both
ultrasound and amniocentesis. Of those who did chose to continue on to a
procedure, 24% chose to have ultrasound only and 76% chose to have an
ultrasound and amniocentesis.

Figure 2. Graph of the number of decisions made in each
decision category. 134 total patients, 12 chose no procedure
(decision = 0). 29 chose ultrasound only (decision = 1). 93
chose ultrasound and amniocentesis (decision = 2).

Figure 3 shows the decision made when previous children were
healthy versus unhealthy. Here, only those patients with previous children
were considered. The plot shows that some patients made each decision option
if their previous children were healthy. However, while the sample size is
small, this also shows that none of the patients who had unhealthy children

chose to go without any procedure. This could indicate that the presence of a
previously unhealthy child might influence the patient’s decision towards
having some procedure rather than no procedure at all, but the chi-square test
showed that these two factors were independent (X2=0.64; df=2; p=0.73).

57

3

16

1

6

Figure 3. Previous children healthy or not versus decision
made. For previous children healthy 0=healthy, 1=at least
one unhealthy child. For decision, 0=no procedure,
1=ultrasound only, 2=ultrasound and amniocentesis. The
numbers adjacent to the points indicate the number of
patients in each category.

Figure 4 is a scatter plot of the patient’s age versus the screencalculated risk is defined by personal medical history. The calculated risk is
calculated as a percentage, such as 0.1% chance of genetic abnormality in the
fetus, which corresponds to a graph value of 0.01. There was no relationship

between patient age and the calculated risk (F=0.008; df=1; p=0.929).
Indicating that the two factors are independent of each other

Figure 4. Age v. calculated risk. Calculated risk is given as a
percentage, where .01 means 1% chance of an abnormality
occurring in the fetus.
Figure 5 shows the calculated risk versus the decisions made.
Regardless of risk, most patients chose to have ultrasound with amniocentesis.
Those who chose no procedure at all had lower risks, although these were not
statistically significant (F=0.391; df=2; p=0.677). The calculated risk is
calculated as a percentage, such as 0.1% chance of genetic abnormality in the
fetus, which corresponds to a graph value of 0.01.

Figure 5. Calculated risk v. decision made. For decision, 0=no
procedure, 1=ultrasound only, 2=ultrasound and amniocentesis.
Calculated risk is given as a percentage, where .01 means 1% chance
of an abnormality occurring in the fetus.

Figure 6 is a scatter plot of average income of zip code versus decision
made. In this analysis, income had no influence on the decision made by the
patient (F=0.461; df=2, 131; p=0.631).

Figure 7. Average income of each decision option. Income is in
dollars. For decision, 0=no procedure, 1=ultrasound only,
2=ultrasound and amniocentesis.

Figure 8 is the average calculated risk of each decision option. Of each
decision option, the average calculated risk was calculated and plotted. The
calculated risk is calculated as a percentage, such as 0.1% chance of genetic
abnormality in the fetus, which corresponds to a graph value of 0.01. The
results indicate that there are no significant differences in calculated risk for
the three decision categories (F=0.391; df=2,113; p=0.677). Although the data
are not statistically significant, a trend can be seen where those with lower
percentages choose no procedure. A Power Test was done which indicated
that this trend would become statistically significant with a sample size of
over 890.

Figure 8. Average calculated risk of each decision. For decision,
0=no procedure, 1=ultrasound only, 2=ultrasound and
amniocentesis. Calculated risk is given as a percentage, where .01
means 1% chance of an abnormality occurring in the fetus.

Discussion
The previous results were organized by the logical progression of
questions asked about the data and they will be discussed here in the same
order. The goal of the study was to examine the factors affecting patient
choice of non-invasive screens versus invasive testing. Of the factors
analyzed, the calculated risk is the best predictor of testing choice. The higher
a woman’s calculated risk of genetic abnormality in the fetus, the more likely
she was to continue onto invasive testing. This is especially interesting
because it raises the question of understanding values of risk presented by a
health professional.
Figure 1 is a graph based on Hook’s values of population risk of
genetic disorders at a certain age. This supports the premise that as women
increase in age, the risk of a chromosomal abnormality occurring in their
pregnancy also increases. Before the age of 35, the risk of a disorder in
pregnancy is relatively low and has a very gradual slope of increase until the
age of 35. However, after the age of 35, the slope and risk of disorder in
pregnancy increase exponentially. This explains the concern for pregnancies
in women who are older and supports genetic counseling as an option for
women who have pregnancies later in life. The data are a reference to
compare population risk to screen calculated risk.
Figure 2 provided the number of decisions made in each category,
whether it was no further procedures, ultrasound only, or amniocentesis and
ultrasound. These data showed that most women chose to proceed on to at

least some procedure rather than none. Also, the data show a three to one ratio
of women who chose amniocentesis and ultrasound to ultrasound only. From
this, it can be determined that women who are presented with an elevated risk
are nine times more likely to chose some sort of procedure to obtain further
information about their possible high risk pregnancy. This can be explained by
a need for more information in the event of a possible complication in
pregnancy.
There are also readily apparent ascertainment biases here. In order for
a chart to qualify for selection, the patients first had to see an obstetrician and
agree to have one of the prenatal screens. They had to return to their
obstetrician to receiver the abnormal results and then agree to see a genetic
counselor to discuss their results. Since all of these levels give the patient the
option to eschew information, those who passed all these levels of selection
clearly wanted information about their pregnancy. Therefore, they are already
more likely to seek more information about their pregnancy in the form of
another procedure, which explains the high occurrence of the choice to at least
have an ultrasound after an abnormal result.
Figure 3 shows the analysis of whether having a previous child with a
genetic abnormality influenced the choice of testing in the current pregnancy.
Statistical analysis showed that the data were not statistically significant, but a
trend can be seen. If the patients had previous children that were healthy, this
did not influence testing choice. If the patients had previous children who
were unhealthy, they chose at least some procedure. This also shows that none

of the patients who had unhealthy children chose to go without any procedure.
However, it should be noted that the sample size is small. This could indicate
that the presence of a previously unhealthy child might influence the patient’s
decision towards having some procedure rather than no procedure at all. The
possibility of recurrence of a genetic abnormality seems to predict that women
will chose to have at least some procedure to seek more information about
their possible high risk pregnancy.
Figure 4 provided an analysis of a patient’s age and her screen
calculated risk. The data were not statistically significant, so there was no
clear correlation in the data. This indicates that calculated risk is dependant on
personal medical history. This is interesting because population risk is
influenced by age whereas calculated risk is not influenced by age.
Figure 5 shows the analysis of the screen-calculated risk and the
decision made. Overall, these data show that most patients chose to have
ultrasound and amniocentesis, which was observed previously as well. A trend
can be seen where those with higher screen-calculated risks mostly chose at
least an ultrasound over no procedure at all. However, since the data were not
statistically significant, screen calculated risk does not affect the decision that
is made.
Figures 6 and 7 examine whether income had an effect on the patient’s
testing choice. This was analyzed because income is often a predictor of level
or education, and level of education is often a predictor of a person’s ability to
perceive statistics. Unfortunately, the education level of the patient was not

available, so income had to be used as a best approximation. Income was not
listed on the patient chart, so instead the median income of the patient’s zip
code was used. The data were not statistically significant, so the analysis of
the data did not clearly show that income influenced patient decision. This is
understandable because the data for income were not as accurate as desired for
each patient. In a future study, it might be interesting to consider the decision
made in light of the patient’s education level, to see whether this had an effect
on patient testing choice.
Figure 8 is support for the hypothesis that increased screen-calculated
risk is a predictor of testing choice. A clear trend can be seen, where the
higher a patient’s calculated risk, the more likely she was to choose to have a
procedure that would provide more information about her possible high-risk
pregnancy. Also, it is interesting to note the difference in the average risk of
each choice. The average calculated risk of those who chose to not have any
procedure is half of the average calculated risk of those who chose further
procedures. However, the trend is not statistically significant at this sample
size.
The influence of elevated calculated risk is interesting because it raises
the question of patient understanding of values of risk presented by a genetic
counselor. Further studies involving surveys of patient understanding of
statistics and education levels would be helpful in furthering the
understanding of factors that my influence patient testing choice. This
research has future implications for the genetic counseling field. The more

information there is concerning testing implications and testing choice, the
better the care that health professionals will be able to provide.
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Capstone Summary

Genetic counseling can be defined as a “process in which a genetic
counselor educates families or individuals about their risk of passing on a
genetic predisposition for certain disorders to future generations” (“National
Society of Genetic Counselors”). To achieve this goal, a genetic counselor
will explain and discuss the patient’s current medical situation with the patient
in order to inform and educate. During this counseling, the patients will be
presented with the medical facts as well as a possible diagnosis. They will be
taken through the likely progression of the disorder as well as possible
treatments or cures. Another goal of the genetic counseling session is for the
patient to understand the inheritance of their possible affliction and how
personal medical history has contributed to the possible occurrence. With
clear explanation of this information, the genetic counselor will also provide
options, such as testing and screens or support and referrals to other
specialists. Overall, the goal of the genetic counselor is to inform patients of
how genetic history can affect medical future.
Although genetic counseling can ideally be provided to any patient for
any medical situation, genetic counseling is especially commonly offered to
pregnant women. There are many medical factors that might cause a woman
to have a “high-risk pregnancy,” and if she does, she will likely be referred to
a genetic counselor. The possible factors that can denote a possible high-risk
pregnancy are many, each with a medical basis that might affect the
pregnancy adversely.

Currently it is routine to offer pregnant women serum screens that can
test the mother’s blood for indicators of abnormalities in the pregnancy.
Abnormal maternal serum marker screening results will cause a woman to be
referred to a genetic counselor for discussion of risk in the pregnancy. After
an abnormal result and consultation with a genetic counselor, the patient has
the option to continue onto more invasive testing. Although there are many
maternal serum marker screens, two of the most common are the Triple
Screen and the Maternal Serum Alpha-Fetoprotein (MSAFP).
Once either of these screens has established an abnormal level of
analytes, possibly indicating a disorder in the fetus, the patient has the option
to continue on to an ultrasound or a more invasive form of testing. The most
common invasive test performed in this situation is amniocentesis, which
carries a low risk of pregnancy complications.
This decision to move from non-invasive testing to more definitive
invasive testing in the case of a pregnancy with genetic disorder risk is one
that probably entails many different factors. The various factors that might
affect this decision are of particular interest to me, in that they may be
predictive of testing choice and they can show the effect of testing on patient
choice. While the actual factors that can affect this decision are numerous, the
ones that can be evaluated are age of the patient, the patient’s population risk
for a disorder of the fetus, the patient’s screen calculated risk of disorder in
the fetus, previous children and whether those previous children are healthy or
not. Marital status, previous miscarriages, a family history of genetic

disorders, a family history of miscarriage or stillbirth, and the patient’s
ethnicity were also extracted from the charts, but preliminary analysis did not
yield any results with statistical significance. Another factor that might affect
the decision to continue onto invasive testing is the income of the patient, as it
might denote the education level of the patient and her ability to perceive
statistics and calculated risk. As each of these affects the patient’s outlook,
they can be factors that affect the patient’s choice to continue with invasive
testing after a non-invasive screen produces abnormal results.
In order to conduct a study that evaluates the possible factors that
might affect a patients testing decision, subjects that fit certain criteria were
obtained. These patients were seen in Dr. Robert Roger Lebel’s practice in
Glen Ellyn, Illinois. From these patients, I selected those that fit specific
criteria. Patient records were available for women who elected to have one of
the two screens and received consultation from a genetic counselor.
Afterwards they had the option to have no further procedures, ultrasound only,
or ultrasound with amniocentesis. The data was recorded and analyzed.
One of the limiting factors of the data used can be attributed to
ascertainment bias. Since there are many levels of health professional visits
that the patient must attend before the patient qualified for my criteria, these
limiting factors must be discussed. In order for a chart to qualify for selection,
the patients first had to see an obstetrician and agree to have one of the
prenatal screens. They had to return to their obstetrician to receive the
abnormal results and then agree to see a genetic counselor to discuss their

results. Since all of these levels give the patient the option to eschew
information, those who passed all these levels of selection clearly wanted
information about their pregnancy. Therefore, they are already more likely to
seek more information about their pregnancy in the form of another
procedure, which explains the high occurrence of the choice to at least have an
ultrasound after an abnormal result.
Of the factors analyzed, a trend in the data can be seen. The higher a
woman’s calculated risk of genetic abnormality in the fetus, the more likely
she was to continue on to invasive testing. The average calculated risk of the
choice to not have any procedure is approximately two times lower than the
average calculated risk of the further procedure choices. This is especially
interesting because it raises the question of understanding values of risk
presented by a health professional. However, this trend is not statistically
significant because of the small sample size.
Further studies involving surveys of patient understanding of statistics
and education levels would be helpful in furthering the understanding of
factors that my influence patient testing choice. This research has future
implications for the field of genetic counseling. The more information there is
concerning testing implications and testing choice, the better the care that
health professionals will be able to provide.

